Clinical Trial Update: An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1) [Phase 3]

View source ↗

Summary

This document reports a Phase 3 clinical trial evaluating the safety and efficacy of TSND-201 for post-traumatic stress disorder, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• TSND-201

Snippet

Sponsor: Transcend Therapeutics | Conditions: Post Traumatic Stress Disorder | Phase 3 | Status: RECRUITING